α-methylidene-γ-butyrolactones:: Synthesis and evaluation of quinolin-2(1H)-one derivatives

被引:18
作者
Wang, TC
Chen, YL
Tzeng, CC [1 ]
Liou, SS
Tzeng, WF
Chang, YL
Teng, CM
机构
[1] Kaohsiung Med Coll, Sch Chem, Kaohsiung 807, Taiwan
[2] Tajen Jr Coll Pharm, Pingtung, Peoples R China
[3] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei 100, Taiwan
关键词
D O I
10.1002/hlca.19980810517
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As a continuation of our previous studies on the synthesis and antiplatelet activity of qninolin-2(1H)-ones with an alpha-methyilidene-gamma-butyrolactone substituted at O(8), the O(6)- and N(1)-substituted isomers were synthesized and evaluated for antiplatelet activity against thrombin (Thr)-, arachidonic acid (AA)-, collagen (Col)-, and platelet-activating-factor (PAF)-induced aggregation in washed rabbit platelets. These compounds were synthesized from 6-hydroxyquinolin-2(1H)-one via alkylation and Reformatsky-type condensation (Schemes 1 and 2). All of them were found to inhibit the platelet aggregation perfectly which was induced by AA and Col. 6-Substituted isomers 5b-g exhibited very strong inhibitory activities against AA- and PAF-induced aggregation and are approximately ten times more potent than their 8-substituted counterparts. However, the 1-substituted (11a and 11b) and the 1,6-disubstituted (6) counterparts were relatively inactive. Their effects on the Ca2+-dependent vasoconstriction induced by high K+, and the phasic and tonic vasoconstrictions induced by norepinephrine (NE) in rat aorta were also evaluated. Except 5g, all of them were found to have significant inhibitory activity on the NE-induced phasic and tonic vasoconstrictions. Compounds 6 and 11b also exhibited strong inhibitory activity on high-K+ medium, Ca2+-induced vasoconstriction.
引用
收藏
页码:1038 / 1047
页数:10
相关论文
共 11 条
  • [1] Synthesis of coumarin derivatives as inhibitors of platelet aggregation
    Chen, YL
    Wang, TC
    Lee, KH
    Tzeng, CC
    [J]. HELVETICA CHIMICA ACTA, 1996, 79 (03) : 651 - 657
  • [2] Chen YL, 1996, CHEM PHARM BULL, V44, P1591
  • [3] Liou SS, 1997, CHEM PHARM BULL, V45, P1777
  • [4] NISHI T, 1983, CHEM PHARM BULL, V31, P798
  • [5] OBRIEN JR, 1962, J CLIN PATHOL, V15, P452
  • [6] TENG CM, 1988, THROMB HAEMOSTASIS, V59, P304
  • [7] Synthesis and evaluation of α-methylidene-γ-butyrolactone bearing flavone and xanthone moieties
    Tzeng, CC
    Zhao, YL
    Chen, YL
    Liou, SS
    Wang, TC
    Chang, YL
    Teng, CM
    [J]. HELVETICA CHIMICA ACTA, 1997, 80 (08) : 2337 - 2344
  • [8] Synthesis and evaluation of 2-{[(2-oxo-1H-quinolin-8-yl)oxy]methyl}-substituted alpha-methylidene-gamma-butyrolactones
    Tzeng, CC
    Chen, YL
    Wang, CYJ
    Wang, TC
    Chang, YL
    Teng, CM
    [J]. HELVETICA CHIMICA ACTA, 1997, 80 (04) : 1161 - 1168
  • [9] Wang TC, 1997, SYNTHESIS-STUTTGART, P87
  • [10] Antiplatelet alpha-methylidene-gamma-butyrolactones: Synthesis and evaluation of quinoline, flavone, and xanthone derivatives
    Wang, TC
    Chen, YL
    Tzeng, CC
    Liou, SS
    Chang, YL
    Teng, CM
    [J]. HELVETICA CHIMICA ACTA, 1996, 79 (06) : 1620 - 1626